These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 39121469)
21. Determining the Optimal Vaccination Schedule for Herpes Zoster: a Cost-Effectiveness Analysis. Le P; Rothberg MB J Gen Intern Med; 2017 Feb; 32(2):159-167. PubMed ID: 27743284 [TBL] [Abstract][Full Text] [Related]
22. Urban-rural differences in preferences for traditional Chinese medicine services among chronic disease patients: a discrete choice experiment. Jiang F; Feng Y; Zong W; Xue J; Chen W; Qizhi L; Zhang J; Xu A BMC Complement Med Ther; 2024 Oct; 24(1):369. PubMed ID: 39402534 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Bilcke J; Marais C; Ogunjimi B; Willem L; Hens N; Beutels P Vaccine; 2012 Jan; 30(3):675-84. PubMed ID: 22120193 [TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years. Le P; Rothberg MB Ann Intern Med; 2015 Oct; 163(7):489-97. PubMed ID: 26344036 [TBL] [Abstract][Full Text] [Related]
25. Community and patient values for preventing herpes zoster. Lieu TA; Ortega-Sanchez I; Ray GT; Rusinak D; Yih WK; Choo PW; Shui I; Kleinman K; Harpaz R; Prosser LA Pharmacoeconomics; 2008; 26(3):235-49. PubMed ID: 18282017 [TBL] [Abstract][Full Text] [Related]
26. Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults. McGirr A; Van Oorschot D; Widenmaier R; Stokes M; Ganz ML; Jung H; Varghese L; Curran D Appl Health Econ Health Policy; 2019 Oct; 17(5):723-732. PubMed ID: 31250218 [TBL] [Abstract][Full Text] [Related]
27. Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis. Wang Q; Yang L; Li L; Liu C; Jin H; Lin L JMIR Public Health Surveill; 2023 Mar; 9():e43893. PubMed ID: 36892937 [TBL] [Abstract][Full Text] [Related]
28. Willingness to vaccinate against herpes zoster in Chinese urban population: a mixed-methods study. Wang M; Hu M; Wang Y; Long C; Xia Y; Zhu D; Zhao W; Yuan B; He P BMJ Open; 2023 Dec; 13(12):e079115. PubMed ID: 38149414 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study. Valente N; Lupi S; Stefanati A; Cova M; Sulcaj N; Piccinni L; ; Gabutti G BMJ Open; 2016 Oct; 6(10):e011539. PubMed ID: 27797989 [TBL] [Abstract][Full Text] [Related]
30. Parental Preferences of Influenza Vaccination for Children in China: A National Survey with a Discrete Choice Experiment. Jiang M; Gong Y; Fang Y; Yao X; Feng L; Zhu S; Peng J; Shi X Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206343 [TBL] [Abstract][Full Text] [Related]
31. A systematic literature review to assess the burden of herpes zoster disease in China. Yin D; Van Oorschot D; Jiang N; Marijam A; Saha D; Wu Z; Tang H; Diaz-Decaro J; Watson P; Xie X; Ren Y; He Y; Feng Y Expert Rev Anti Infect Ther; 2021 Feb; 19(2):165-179. PubMed ID: 32997550 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of vaccination against herpes zoster. de Boer PT; Wilschut JC; Postma MJ Hum Vaccin Immunother; 2014; 10(7):2048-61. PubMed ID: 25424815 [TBL] [Abstract][Full Text] [Related]
33. Individual preferences for COVID-19 vaccination in China. Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140 [TBL] [Abstract][Full Text] [Related]
34. Parental willingness to pay and preference for human papillomavirus vaccine for girls aged 9-14 in subsidy scenarios in Shanghai, China. Zhou W; Lu X; Lu J; Zhang Q; Fu X; Sun X; Guo X; Lu Y Hum Vaccin Immunother; 2024 Dec; 20(1):2372883. PubMed ID: 38977424 [TBL] [Abstract][Full Text] [Related]
35. [A study on knowledge, attitude, and vaccination behavior of herpes zoster vaccine among urban residents in selected areas of China]. Wang M; Long C; Hu MZ; Wang YS; Xia YQ; Yuan BB; Zhu DW; He P Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Jun; 44(6):899-904. PubMed ID: 37380410 [No Abstract] [Full Text] [Related]
36. Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment. Veldwijk J; Lambooij MS; van Gils PF; Struijs JN; Smit HA; de Wit GA BMC Public Health; 2013 Nov; 13():1099. PubMed ID: 24289831 [TBL] [Abstract][Full Text] [Related]
37. Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. Patterson BJ; Herring WL; Van Oorschot D; Curran D; Carrico J; Zhang Y; Ackerson BK; Bruxvoort K; Sy LS; Tseng HF J Manag Care Spec Pharm; 2020 Dec; 26(12):1567-1575. PubMed ID: 33043821 [TBL] [Abstract][Full Text] [Related]
38. Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults. You JHS; Ming WK; Tsang OT; Chan PK PLoS One; 2019; 14(1):e0210005. PubMed ID: 30608953 [TBL] [Abstract][Full Text] [Related]
39. Parental preferences for rotavirus vaccination for their children under 5 years old in China: A discrete choice experiment. Ma W; Zhang L; Ren D; Meng X; Yin J; Sun Q Hum Vaccin Immunother; 2023 Dec; 19(1):2179222. PubMed ID: 36794417 [TBL] [Abstract][Full Text] [Related]
40. Older adults preferences for long-term caregivers in China: a discrete choice experiment. Leng A; Liu J; Maitland E; Li S; Nicholas S; Ma B; Wang J Public Health; 2024 Jun; 231():158-165. PubMed ID: 38692091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]